Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05414903 · ClinicalTrials.gov registry record · NA

Reading Outcomes in Children With Vestibular Loss

A NA study of Hearing Loss, Sensorineural and Vestibular Disorder, sponsored by Father Flanagan's Boys' Home.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05414903: Recruiting NA study of Hearing Loss, Sensorineural and Vestibular Disorder, sponsored by Father Flanagan's Boys' Home.

NCT05414903 is a NA study of Hearing Loss, Sensorineural and Vestibular Disorder that is actively recruiting participants, run by Father Flanagan's Boys' Home. The registered enrollment target is 90 participants, below the 782-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05414903, a NA study of Hearing Loss, Sensorineural and Vestibular Disorder, is actively recruiting participants, sponsored by Father Flanagan's Boys' Home.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Vestibular loss can co-occur with hearing loss causing dual sensory deficits. This project examines vestibular loss as a contributing factor to reading difficulties for children with hearing loss, where previously only the effects of hearing loss and subsequent language difficulties have been considered. These results are expected to influence the identification and habilitation of vestibular loss in children with hearing loss.

Primary Outcome

The dynamic visual acuity test measures the ability to see clearly during head movement. 3 type of head movement will be assessed: Active (participant moves their own head), Passive (Investigator moves participant's head) and impulse (Investigator moves participant's head).

Interventions

  • BEHAVIORAL Dynamic Visual Acuity
  • BEHAVIORAL Reading Outcomes
  • BEHAVIORAL Static Visual Acuity

Study Locations (1)

Nebraska

  • Boys Town National Research Hospital - Omaha

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2022-06-06
Est. Completion 2026-06-30
Phase NA
Father Flanagan's Boys' Home

16 total trials

What NCT05414903 shows while recruiting

NCT05414903 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 782-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 3 interventions - of which Dynamic Visual Acuity is the first listed.

NCT05414903 reports a single indexed study location in Nebraska.

Frequently Asked Questions

What is clinical trial NCT05414903 about?

NCT05414903 is a clinical study titled "Reading Outcomes in Children With Vestibular Loss". Vestibular loss can co-occur with hearing loss causing dual sensory deficits. This project examines vestibular loss as a contributing factor to reading difficulties for children with hearing loss, where previously only the effects of hearing loss and subsequent language difficulties have been consid...

What is the current status of trial NCT05414903?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2022-06-06. Estimated completion is 2026-06-30.

What conditions does trial NCT05414903 study?

This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Vestibular Disorder.

What interventions are being tested in trial NCT05414903?

The interventions under investigation include: Dynamic Visual Acuity (BEHAVIORAL), Reading Outcomes (BEHAVIORAL), Static Visual Acuity (BEHAVIORAL).

Who is sponsoring clinical trial NCT05414903?

This trial is sponsored by Father Flanagan's Boys' Home, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05414903 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss, Sensorineural

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05414903's enrollment target sits among peer trials

90 7th of 20 higher than 14 of 20 other Hearing Loss, Sensorineural trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05414903, the US trial registry maintained by the National Library of Medicine. NCT05414903 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.